drugset / Trial / NCT01392768

Efficacy and Safety of Levetiracetam in Partial Seizures Control, With or Without Secondary Generalization

NCT01392768

Phase 3 Completed 126 enrolled Ache Laboratorios Farmaceuticos S.A.
RandomizedParallel-groupQuadruple-blindTreatment

Summary

The purpose of this study is to determine whether levetiracetam as adjunctive therapy is effective in the treatment of partial seizures, with or without secondary generalization, associated with refractory focal epilepsy.

Timeline

Start
2013-01
Primary completion
2015-07
Completion
2015-08

Drugs

EvaluationDrugModalityDoseRoute
Subject Levetiracetam Other / unclassified 100 mg/ml Oral
Subject Levetiracetam Other / unclassified 500 mg Oral
Subject Levetiracetam Other / unclassified 1000 mg Oral

Indications